Precision Medicine Market Report – Research, Industry Analysis Reports and Market Demands

Global Precision Medicine Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Precision Medicine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Precision Medicine Market Size Growth Rate by Product
- 1.4.2 Diagnostics
- 1.4.3 Therapies
1.5 Market by End User
- 1.5.1 Global Precision Medicine Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Neurosciences
- 1.5.4 Immunology
- 1.5.5 Respiratory
- 1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Precision Medicine Market Size
- 2.1.1 Global Precision Medicine Revenue 2014-2025
- 2.1.2 Global Precision Medicine Sales 2014-2025
2.2 Precision Medicine Growth Rate by Regions
- 2.2.1 Global Precision Medicine Sales by Regions
- 2.2.2 Global Precision Medicine Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Precision Medicine Sales by Manufacturers
- 3.1.1 Precision Medicine Sales by Manufacturers
- 3.1.2 Precision Medicine Sales Market Share by Manufacturers
- 3.1.3 Global Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.2 Precision Medicine Revenue by Manufacturers
- 3.2.1 Precision Medicine Revenue by Manufacturers (2014-2019)
- 3.2.2 Precision Medicine Revenue Share by Manufacturers (2014-2019)
3.3 Precision Medicine Price by Manufacturers
3.4 Precision Medicine Manufacturing Base Distribution, Product Types
- 3.4.1 Precision Medicine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Precision Medicine Product Type
- 3.4.3 Date of International Manufacturers Enter into Precision Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Precision Medicine Sales by Product
4.2 Global Precision Medicine Revenue by Product
4.3 Precision Medicine Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Precision Medicine Breakdown Data by End User

6 North America

6.1 North America Precision Medicine by Countries
- 6.1.1 North America Precision Medicine Sales by Countries
- 6.1.2 North America Precision Medicine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Precision Medicine by Product
6.3 North America Precision Medicine by End User

7 Europe

7.1 Europe Precision Medicine by Countries
- 7.1.1 Europe Precision Medicine Sales by Countries
- 7.1.2 Europe Precision Medicine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Precision Medicine by Product
7.3 Europe Precision Medicine by End User

8 Asia Pacific

8.1 Asia Pacific Precision Medicine by Countries
- 8.1.1 Asia Pacific Precision Medicine Sales by Countries
- 8.1.2 Asia Pacific Precision Medicine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Precision Medicine by Product
8.3 Asia Pacific Precision Medicine by End User

9 Central & South America

9.1 Central & South America Precision Medicine by Countries
- 9.1.1 Central & South America Precision Medicine Sales by Countries
- 9.1.2 Central & South America Precision Medicine Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Precision Medicine by Product
9.3 Central & South America Precision Medicine by End User

10 Middle East and Africa

10.1 Middle East and Africa Precision Medicine by Countries
- 10.1.1 Middle East and Africa Precision Medicine Sales by Countries
- 10.1.2 Middle East and Africa Precision Medicine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Precision Medicine by Product
10.3 Middle East and Africa Precision Medicine by End User

11 Company Profiles

12 Future Forecast

12.1 Precision Medicine Market Forecast by Regions
- 12.1.1 Global Precision Medicine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Precision Medicine Revenue Forecast by Regions 2019-2025
12.2 Precision Medicine Market Forecast by Product
- 12.2.1 Global Precision Medicine Sales Forecast by Product 2019-2025
- 12.2.2 Global Precision Medicine Revenue Forecast by Product 2019-2025
12.3 Precision Medicine Market Forecast by End User
12.4 North America Precision Medicine Forecast
12.5 Europe Precision Medicine Forecast
12.6 Asia Pacific Precision Medicine Forecast
12.7 Central & South America Precision Medicine Forecast
12.8 Middle East and Africa Precision Medicine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Precision Medicine Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics in 2016 is about 68%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the revenue in 2016 is 4.3 billion USD.
Germany is the largest consumption place, with a consumption market share nearly 22% in 2016. Following Germany, France is the second largest consumption place with the consumption market share of 18%.
The global Precision Medicine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Precision Medicine market based on company, product type, end user and key regions.

This report studies the global market size of Precision Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Precision Medicine in these regions.
This research report categorizes the global Precision Medicine market by top players/brands, region, type and end user. This report also studies the global Precision Medicine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
IBM
GE Healthcare
Illumina
Roche
Laboratory Corporation of America Holdings
Thermo Fisher Scientific
Novartis
Abbott Laboratories
Almac Group
Intel Corporation
Biomrieux Sa
Cepheid
Qiagen
Randox Laboratories
Healthcore

Market size by Product
Diagnostics
Therapies
Market size by End User
Oncology
Neurosciences
Immunology
Respiratory
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Precision Medicine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Precision Medicine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Precision Medicine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Precision Medicine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Precision Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Precision Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.